About Celltrio
Celltrio is a company based in Santa Clara (United States) founded in 2018. Celltrio has raised $15 million across 1 funding round from investors including Premier Partners. Celltrio offers products and services including RoboCell, RoboStor, and Bioflow. Celltrio operates in a competitive market with competitors including Multiply Labs, Shenzhen Shenyan Biotechnology, ThermoGenesis, Cellular Origins and Cytera, among others.
- Headquarter Santa Clara, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$15 M (USD)
in 1 rounds
-
Latest Funding Round
$15 M (USD), Series B
Jun 17, 2025
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Celltrio
Celltrio offers a comprehensive portfolio of products and services, including RoboCell, RoboStor, and Bioflow.
Automates cell maintenance, culture, and assays for biological research.
Handles LN2 storage and retrieval for biobanking applications.
Manages cell culture processes and data monitoring in real-time.
People of Celltrio
Unlock access to complete
Funding Insights of Celltrio
Celltrio has successfully raised a total of $15M through 1 strategic funding round. The most recent funding activity was a Series B round of $15 million completed in June 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Celltrio
Celltrio has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Premier Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity & venture capital firm
|
Locked | Locked | Locked |
Investor details for Celltrio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Celltrio
Investment portfolio details for Celltrio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Celltrio
Detailed financials for Celltrio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Celltrio Comparisons
Peer comparison for Celltrio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Celltrio
Celltrio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Multiply Labs, Shenzhen Shenyan Biotechnology, ThermoGenesis, Cellular Origins and Cytera, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Precision medicines are manufactured via robotic systems for cell therapies.
|
|
| Locked | Locked | Locked |
Automated cell processing systems are developed for gene therapies.
|
|
| Locked | Locked | Locked |
Automated technologies for cell-based therapeutics and bio-processing are developed.
|
|
| Locked | Locked | Locked |
Automates cell therapy manufacturing through partnerships and robotics integration.
|
|
| Locked | Locked | Locked |
Automated cell culture devices using T-flasks and incubators are developed.
|
|
| Locked | Locked | Locked |
Robotic solutions for life science research are developed.
|
Detailed competitors of Celltrio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Celltrio
Complete news archive for Celltrio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Celltrio
Celltrio was founded in 2018 and raised its 1st funding round 7 years after it was founded.
Celltrio is headquartered in Santa Clara, United States. It is registered at Santa Clara, California, United States.
Celltrio is a funded company, having raised a total of $15M across 1 funding round to date.
Developer of automated biobanking and cell culture systems. It has developed CryoStor and RoboStor lines of liquid nitrogen freezers for biobanking applications. The company has also developed integrated robotic solutions which combine incubators, centrifuges and liquid handlers using software and LIMS systems.
Celltrio's top competitors include Multiply Labs, ThermoGenesis and Shenzhen Shenyan Biotechnology.
Celltrio offers RoboCell, RoboStor, and Bioflow.
Celltrio has 1 investor. Key investors include Premier Partners.